Superior Planning, LLC’s Edwards Lifesciences EW Stock Holding History

Superior Planning, LLC’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$17.4K	Buy	+202	New	+$18K	0.01%	742

Other funds holding EW

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return

Superior Planning, LLC's EW Position: Q3 2026 in Review

Superior Planning, LLC opened a new position in Edwards Lifesciences (EW) in Q3 2026: 202 shares worth $17.4K. The stake represents 0.01% of the portfolio and ranks #742 among its holdings.

976 funds tracked by Wall St. Rank hold EW as of Q3 2026.

Superior Planning, LLC held 202 shares of Edwards Lifesciences worth $17.4K as of Q3 2026.
Edwards Lifesciences was a new Superior Planning, LLC position in Q3 2026.
Edwards Lifesciences made up 0.01% of Superior Planning, LLC's portfolio in Q3 2026, its #742 holding.
976 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on Superior Planning, LLC's 13F filing for Q3 2026, filed 12 Nov 2026.